1. Home
  2. JYNT vs THRD Comparison

JYNT vs THRD Comparison

Compare JYNT & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • THRD
  • Stock Information
  • Founded
  • JYNT 2010
  • THRD 2019
  • Country
  • JYNT United States
  • THRD United States
  • Employees
  • JYNT N/A
  • THRD N/A
  • Industry
  • JYNT Multi-Sector Companies
  • THRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • THRD Health Care
  • Exchange
  • JYNT Nasdaq
  • THRD Nasdaq
  • Market Cap
  • JYNT 170.1M
  • THRD 164.2M
  • IPO Year
  • JYNT 2014
  • THRD 2022
  • Fundamental
  • Price
  • JYNT $9.99
  • THRD $5.15
  • Analyst Decision
  • JYNT Strong Buy
  • THRD Hold
  • Analyst Count
  • JYNT 2
  • THRD 3
  • Target Price
  • JYNT $15.50
  • THRD $5.00
  • AVG Volume (30 Days)
  • JYNT 62.5K
  • THRD 1.1M
  • Earning Date
  • JYNT 05-08-2025
  • THRD 05-08-2025
  • Dividend Yield
  • JYNT N/A
  • THRD N/A
  • EPS Growth
  • JYNT N/A
  • THRD N/A
  • EPS
  • JYNT N/A
  • THRD N/A
  • Revenue
  • JYNT $52,789,479.00
  • THRD N/A
  • Revenue This Year
  • JYNT $10.88
  • THRD N/A
  • Revenue Next Year
  • JYNT $12.11
  • THRD N/A
  • P/E Ratio
  • JYNT N/A
  • THRD N/A
  • Revenue Growth
  • JYNT N/A
  • THRD N/A
  • 52 Week Low
  • JYNT $9.58
  • THRD $3.18
  • 52 Week High
  • JYNT $17.82
  • THRD $16.94
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 44.27
  • THRD 76.76
  • Support Level
  • JYNT $9.61
  • THRD $5.11
  • Resistance Level
  • JYNT $10.60
  • THRD $5.25
  • Average True Range (ATR)
  • JYNT 0.52
  • THRD 0.05
  • MACD
  • JYNT 0.06
  • THRD -0.04
  • Stochastic Oscillator
  • JYNT 29.23
  • THRD 27.54

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Share on Social Networks: